News
European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
20h
MedPage Today on MSNGLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA WarnsA potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
‘You have to find your new identity’ – artist who had stroke at 35 creates workshops for people living with acquired brain ...
The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.
In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...
No single food can reduce the risk of stroke; rather, eating a diet plentiful in fruits, vegetables, legumes, nuts, seeds, ...
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...
18h
MedPage Today on MSNGlobal Stroke Deaths Still a Concern, and It's Not Just About Developing CountriesIn 2021, the number of people affected by stroke worldwide exceeded 93.8 million, with over 7.25 million related deaths.
Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...
22h
News-Medical.Net on MSNBetter brain care score linked to lower risk of heart disease and cancerA new study from researchers at Mass General Brigham has found that a higher McCance Brain Care Score not only associates ...
Dr Nor Faizal, currently serving at KPJ Tawakkal Specialist Hospital Kuala Lumpur, said the incident unfolded very quickly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results